Quidel Corporation Faces Neutral Market Rating Amid Profitability Challenges
In a significant market update, William Blair has revised its outlook on Quidel Corporation (NASDAQ:QDEL), a leading diagnostic healthcare manufacturer, revising its stock rating from Outperform to Market Perform. This adjustment comes in the wake of QuidelOrtho's fourth-quarter results and its 2024 guidance, which did not meet the expected thresholds for adjusted EBITDA and adjusted EPS.
Exclusive Access: Unlock Premium, Confidential Insights
Unlock This Exclusive Content—Subscribe Instantly!
Login if you have purchased
